Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grotta

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of the Neurological Sciences|February 17, 2000
Early CT changes of ischemia: limitations of what we knowJ Grotta
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzoleJ Grotta,
Thrombosis and Haemostasis|July 1, 1997
Cerebrovascular disease in young patientsJ Grotta
The New England Journal of Medicine|November 5, 1997
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patientsJ Grotta
Journal of Internal Medicine|January 1, 1995
Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapyJ Grotta
Archives of Neurology|October 1, 1996
Rodent models of stroke limitations. What can we learn from recent clinical trials of thrombolysis?J Grotta
Annals of the New York Academy of Sciences|July 21, 2001
Combination therapy stroke trial. rt-PA +/- lubeluzoleJ Grotta
Stroke|May 1, 1993
Is aspirin effective in preventing strokes in diabetic patients?J Grotta
Circulation|January 21, 1997
Elective stenting of extracranial carotid arteriesJ Grotta
Stroke|April 1, 1993
Secular trends in stroke incidence and mortalityJ Grotta
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of the Neurological Sciences|February 17, 2000
Early CT changes of ischemia: limitations of what we knowJ Grotta
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzoleJ Grotta,
Thrombosis and Haemostasis|July 1, 1997
Cerebrovascular disease in young patientsJ Grotta
The New England Journal of Medicine|November 5, 1997
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patientsJ Grotta
Journal of Internal Medicine|January 1, 1995
Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapyJ Grotta
Archives of Neurology|October 1, 1996
Rodent models of stroke limitations. What can we learn from recent clinical trials of thrombolysis?J Grotta
Annals of the New York Academy of Sciences|July 21, 2001
Combination therapy stroke trial. rt-PA +/- lubeluzoleJ Grotta
Stroke|May 1, 1993
Is aspirin effective in preventing strokes in diabetic patients?J Grotta
Circulation|January 21, 1997
Elective stenting of extracranial carotid arteriesJ Grotta
Stroke|April 1, 1993
Secular trends in stroke incidence and mortalityJ Grotta
Pageof 4